Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.
Gedea Biotech has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in February 2024.
Gedea Biotech's investors include Almi Invest, EIC Accelerator, EISMEA, LU Innovation, SmiLe Incubator.
Gedea Biotech is headquartered in Lund, Sweden.
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections.
Gedea Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gedea Biotech — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/gedea-biotech. Accessed October 18, 2026.
VCBacked. (2024). Gedea Biotech — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/gedea-biotech
{{cite web |title=Gedea Biotech — Funding & Investors |url=https://www.vcbacked.co/company/gedea-biotech |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated